濟民健康(603222.SH):預計半年度淨虧損4600萬元-5500萬元
格隆匯7月11日丨濟民健康(603222.SH)公佈,1、經濟民健康管理股份有限公司財務部初步測算,預計2025年半年度實現歸屬於母公司所有者的淨利潤爲-5,500.00萬元至-4,600.00萬元,與上年同期2,544.50萬元相比,將出現虧損。2、預計2025年半年度實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤爲-5,500.00萬元至-4,600.00萬元。
受美國關稅政策影響,公司安全注射器外銷收入下滑約40%;同時受前期價格調整等影響,安全注射器外銷毛利下滑約82%。受“何清紅私刻印章事件”的影響,公司預充式導管沖洗器和安全注射器(內銷)銷售收入較上年同期下滑約92%,導致相關產品利潤降低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.